Vavassori M, Maccario R, Moretta A, Comoli P, Wack A, Locatelli F, Lanzavecchia A, Maserati E, Dellabona P, Casorati G, Montagna D
Unit of Immunochemistry, DIBIT, H.S. Raffaele Scientific Institute, Milan, Italy.
J Immunol. 1996 Dec 15;157(12):5739-47.
We investigated the contribution of transfer of Ag-experienced donor T cells to the immune reconstitution of allogeneic bone marrow transplantation (BMT) recipients. To this purpose, we used a combination of cell culture methods to isolate tetanus toxoid (TT)-specific T cell clones, and a sensitive and specific heteroduplex analysis to monitor the presence of a particular clonotype using TCR N region sequences. We document that patients after BMT display a small response to TT, entirely accounted for by few donor-derived clones. These patients show a strong polyclonal response to TT vaccination; however, the T cell clones transferred with the transplant can still be detected within the polyclonal T cell lines for up to at least 5 yr after BMT. We also demonstrate that vaccination of donors with TT before BMT results in a more relevant transfer of Ag-experienced T cells, allowing the recipients to mount a strong polyclonal response without need of vaccination. These findings provide a rationale for vaccinating donors to optimize adoptive transfer of protective T cell immunity into recipients, and suggest the possibility of using preventive T cell adoptive therapy in conjunction with marrow infusion.
我们研究了抗原致敏供体T细胞的转移对异基因骨髓移植(BMT)受者免疫重建的作用。为此,我们采用了多种细胞培养方法来分离破伤风类毒素(TT)特异性T细胞克隆,并使用灵敏且特异的异源双链分析,通过TCR N区序列监测特定克隆型的存在。我们记录到,BMT后的患者对TT有微弱反应,这完全由少数供体来源的克隆所导致。这些患者对TT疫苗接种表现出强烈的多克隆反应;然而,移植时转移的T细胞克隆在BMT后至少5年内仍可在多克隆T细胞系中被检测到。我们还证明,在BMT前用TT对供体进行疫苗接种可导致抗原致敏T细胞更有效的转移,使受者无需接种疫苗就能产生强烈的多克隆反应。这些发现为给供体接种疫苗以优化保护性T细胞免疫向受者的过继转移提供了理论依据,并提示了将预防性T细胞过继治疗与骨髓输注联合使用的可能性。